Evidence map›Paper›PMID 41458201›Full record

ArticleChina CDC weekly2025

Serological Survey of Lymphocytic Choriomeningitis Virus (LCMV) Infection - Gansu Province, China, 2023.

Qian Ling, Haizhuo Wu, Xuelian Luo, Maoxing Dong, Qianjin Fan, Hui Sun, Xiaoshu Zhang, Jianguo Xu

Abstract read
In one paragraph

Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qian Ling *Department of Epidemiology and Biostatistics; Center for Infectious Diseases and Policy Research; Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education; Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, China.
Haizhuo Wu *Gansu Provincial Key Laboratory for Etiology of Infectious Disease, Gansu Provincial Center for Disease Control and Prevention, Lanzhou City, Gansu Province, China.
Xuelian LuoNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Maoxing DongGansu Provincial Key Laboratory for Etiology of Infectious Disease, Gansu Provincial Center for Disease Control and Prevention, Lanzhou City, Gansu Province, China.
Qianjin FanNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Hui SunNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Xiaoshu ZhangGansu Provincial Key Laboratory for Etiology of Infectious Disease, Gansu Provincial Center for Disease Control and Prevention, Lanzhou City, Gansu Province, China.
Jianguo XuDepartment of Epidemiology and Biostatistics; Center for Infectious Diseases and Policy Research; Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education; Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

What is already known about this topic?: Lymphocytic choriomeningitis virus (LCMV) is transmitted primarily through rodent excreta, with humans being universally susceptible to infection. Transmission via organ transplantation occurs rarely. The predominantly nonspecific clinical presentation in humans has contributed to LCMV remaining an underrecognized zoonotic pathogen. What is added by this report?: This study provides the first serological confirmation of past LCMV infection among the general population in Gansu Province, with seroprevalence rates of 18.31% by enzyme-linked immunosorbent assay (ELISA) and 1.97% by immunofluorescence analysis (IFA). Priority populations for targeted LCMV prevention and control interventions include rural residents, individuals with lower educational attainment, and agricultural workers. What are the implications for public health practice?: LCMV clinical manifestations overlap with those of pathogens targeted by national sentinel surveillance systems; LCMV should be incorporated into future screening protocols for unidentified infectious agents.

Indexed as

Antibody DetectionLymphocytic Choriomeningitis Virus (LCMV)Neutralization AssaySerological Survey

Identifiers

PMID41458201
PMCPMC12739463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.